Display Settings:

Format

Send to:

Choose Destination
    Cell Metab. 2009 Jul;10(1):48-54.

    Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis.

    Source

    Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA.

    Abstract

    The accumulation of LDL-derived cholesterol in the artery wall is the initiating event that causes atherosclerosis. However, the mechanisms that lead to the initiation of atherosclerosis are still poorly understood. Here, by using endothelial cell-specific transgenesis of the caveolin-1 (Cav-1) gene in mice, we show the critical role of Cav-1 in promoting atherogenesis. Mice were generated lacking Cav-1 and apoE but expressing endothelial-specific Cav-1 in the double knockout background. Genetic ablation of Cav-1 on an apoE knockout background inhibits the progression of atherosclerosis, while re-expression of Cav-1 in the endothelium promotes lesion expansion. Mechanistically, the loss of Cav-1 reduces LDL infiltration into the artery wall, promotes nitric oxide production, and reduces the expression of leukocyte adhesion molecules, effects completely reversed in transgenic mice. In summary, this unique model provides physiological evidence supporting the important role of endothelial Cav-1 expression in regulating the entry of LDL into the vessel wall and the initiation of atherosclerosis.

    PMID:
    19583953
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2735117
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Fig 1
    Fig 3
    Fig 2
    Fig 4

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk